Skip to main content
Home Licenses Page 4

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

Isolere Bio: Inside the journey of a Duke biotech start-up

From an invention in 1999, to start-up creation in 2017, to acquisition in 2023, learn of the twists and turns of Duke start-up Isolere Bio from its co-founders.

Read More

Sparta Biomedical, Dr. Wiley highlighted by WXII 12 News

Professor of Chemistry Dr. Benjamin Wiley was interviewed recently by Winston-Salem TV station WXII 12 News about the synthetic cartilage his lab developed.

Read More

FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

Radius Health, with its eventual partner Stemline Therapeutics/Menarini Group, licensed the cancer indications for this drug in 2017 out of the lab of Dr. Donald McDonnell (Pharmacology and Cancer Biology, SOM).

Read More

PranaQ Secures $3M in Seed Funding

This post first appeared on the PranaQ website. PranaQ, a healthcare technology startup, successfully completed $3M in Seed round funding raising. The round was participated by multiple global venture capital firms, including DSC Investment, Smilegate Investment,…

Read More

Invented at Duke 2022 brings together the university research, innovation, and entrepreneurship community

Members of the Duke research, innovation, and entrepreneurship community gathered for the annual celebration of inventions and inventors, as well as to network with each other and various internal and external partners.

Read More

Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Radius first licensed the indication for this drug discovered out of the Donald McDonnell lab from Duke in 2017.

Read More


Psychologists Terrie Moffitt and Avshalom Caspi develop a measure for your rate of aging By Duke Today Staff Five decades ago, Duke psychologists Terrie Moffitt and Avshalom Caspi began working with a long-term study of…

Read More

Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs

National public-private consortium aims to bring together researchers, oncologists, knowledge institutes and the business community to collaboratively develop better and affordable cancer medicines more quickly DURHAM, N.C., May 3, 2022–(BUSINESS WIRE)–Xilis, Inc., a pioneering company…

Read More

Pitfalls When Speaking with Industry

Great news – a company has asked to set up an introductory meeting to hear more about your invention! These meetings are great opportunities to take steps towards bringing your technology to market through a…

Read More